Repetitive levosimendan in outpatients affected by advanced heart failure: the need for a uniform approach

J Cardiovasc Med (Hagerstown). 2021 Feb 1;22(2):149. doi: 10.2459/JCM.0000000000001090.

Authors

Ciro Maiello¹, Francesco Cacciatore², Cristiano Amarelli¹, Vittorio Palmieri¹, Paolo Golino³

Affiliations

¹ Department of Cardiac Surgery and Transplantation, Heart Transplantation Unit in Adults of the 'Ospedali dei Colli Monaldi-Cotugno-CTO'.
² Department of Translational Medical Sciences and Internal Medicine and Geriatrics, 'Federico II' University of Naples.
³ Department of Cardiology, Cardiology Unit of the 'L. Vanvitelli' University of Campania at the 'Ospedali dei Colli Monaldi-Cotugno-CTO', Naples, Italy.

PMID: 32858638
DOI: 10.2459/JCM.0000000000001090

No abstract available

Publication types

Letter
Comment

MeSH terms

Heart Failure* / drug therapy
Humans
Hydrazones
Outpatients*
Simendan

Substances

Hydrazones
Simendan